← Back to catalogue
Research draft

glucose

vr.tr.glucose · PHY.MAT

Enable an AI agent to identify glucose, assess a particular glucose material or occurrence, and determine which handling, measurement or transformation actions its evidence and intended use support.

Thing Registry Physical world and living systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

Researched by: Codex + Grok

Purpose and description

Enable an AI agent to identify glucose, assess a particular glucose material or occurrence, and determine which handling, measurement or transformation actions its evidence and intended use support.

Glucose is the aldohexose C6H12O6 whose biologically occurring D-enantiomer is the free circulating hexose of animal plasma, the repeating monomer of starch, glycogen and cellulose, and the entry substrate of glycolysis; in water it exists mainly as α- and β-D-glucopyranose in mutarotational equilibrium with a trace open-chain aldehyde.

It can be Select an identification or assay method that distinguishes the relevant glucose form from likely interferents.; Calculate a glucose amount or prepare a target concentration using explicit purity, hydration and concentration bases.; Dissolve, dilute or crystallise glucose when the recorded solvent, temperature and composition support the operation.; Evaluate glucose as a substrate or reagent for a specified enzymatic, fermentation or chemical transformation.; Accept, hold or reject a glucose material against documented criteria for its intended use..

Distinguishing features

Establish monosaccharide identity: glucose is an aldohexose; molecular formula C6H12O6 alone cannot distinguish it from fructose or galactose.

Use a validated structural or separation method to distinguish glucose from galactose, its C4 epimer, and mannose, its C2 epimer.

Establish D/L configuration with stereochemically discriminating evidence when configuration matters; an unspecified glucose label does not independently establish D-glucose.

Distinguish free glucose from glucose units bound in sucrose, maltose or polysaccharides; glucose measured after hydrolysis does not establish the original free-glucose content.

Distinguish anhydrous glucose, glucose monohydrate and glucose dissolved in water through water-content and phase evidence; these presentations do not support interchangeable mass-based calculations.

Scope

+ Chemical identification of glucose, including D/L configuration and alpha/beta anomeric form where relevant

+ Glucose material presented as a solid, solution or constituent of a mixture

+ Glucose amount, concentration, purity and associated measurement evidence

+ Hydration, dissolution, crystallisation and changes in anomeric composition

+ Condition and compatibility evidence supporting a specified handling or transformation

- Diagnosis, treatment and interpretation of blood-glucose results in a patient model

- Whole-organism glucose regulation, metabolic pathways and disease mechanisms

- Complete formulations and performance of foods, medicines or culture media containing glucose

- Full models of neighbouring substances such as fructose, galactose, sucrose and starch

- Design and operation of manufacturing, fermentation and analytical equipment

Characteristics

Stereochemical identity
D-glucose | L-glucose | mixture | unresolved Configuration affects recognition by enzymes and biological systems and determines whether a measurement method addresses the intended glucose species.
Anomeric composition
Alpha and beta fractions with measurement conditions, or unresolved Anomeric composition can change after dissolution and affects interpretation of optical rotation and anomer-sensitive measurements.
Material presentation
Crystalline solid | amorphous solid | solution constituent | other mixture constituent | unresolved Presentation determines which sampling, dissolution and phase-state observations are meaningful.
Hydration and water content
Hydrate identity where established; water mass fraction in % with method Water affects the glucose amount delivered by a weighed material and must be separated from dry-basis purity.
Glucose quantity
g or mol, with identity, hydration and purity basis Supports material balances and preparation of defined glucose quantities.
Glucose concentration
mol/L, g/L or mass fraction, with matrix and reporting basis Enables comparison and dilution calculations without confusing mass concentration, molarity and formulation percentages.
Glucose purity and impurity profile
Glucose mass fraction in % on an explicit basis; identified impurities with amounts or detection limits Other sugars, water and process residues can change measured response and fitness for a proposed use.
Measurement selectivity
Glucose-selective under stated conditions | broader sugar response | unresolved A reducing-sugar result or nonspecific optical measurement cannot automatically be treated as a glucose-specific amount.
Exposure and condition
Recorded temperature, pH where applicable, moisture exposure, duration and observed changes Provides context for interpreting crystallisation, degradation and possible microbial consumption in glucose-containing solutions.
Intended-use qualification
Material linked to a named use, acceptance criteria and supporting evidence Chemical identity alone does not establish that a glucose material is suitable for an analytical, food, pharmaceutical or culture application.

Also called

L-glucosealdehydo-glucoseglucofuranoseglucopyranoseD-glucoseL-glucofuranoseL-glucopyranosealdehydo-L-glucosealdehydo-L-(1-¹⁴C)glucosealdehydo-D-(¹³C₆)glucosealdehydo-D-(6-¹³C)glucosealdehydo-D-(1,6-¹³C₂)glucosealdehydo-D-(6-¹⁴C)glucoseD-glucofuranoseD-(4-¹³C)glucose

Where this came from

wikidata · CC0 1.0

Also registered as vr.tr.glucose

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 5 bundles · 9 layers · 16 findings · 26 questions.

Glucose identity Establish which chemical entity a glucose label or analytical result actually identifies.

Glucose shares its formula with other sugars, occurs in distinct stereochemical forms and can be confused with glucose released from larger carbohydrates.

Sugar discrimination

Separate glucose identity from formula matches and nonspecific sugar responses.

Glucose-specific identification

Record the evidence distinguishing glucose from likely neighbouring sugars and whether the observation concerns free glucose or glucose generated during preparation.

  1. Which evidence distinguishes glucose from fructose, galactose, mannose or other sugars likely to occur in this material? definition
  2. Was glucose present freely in the original sample, or was it released by hydrolysis or another preparation step? boundary

Stereochemical resolution

Resolve D/L configuration and alpha/beta form to the level required by the proposed operation.

Configuration and anomers

Keep D/L configuration distinct from alpha/beta anomeric composition and identify which assignments were measured, documented or left unresolved.

  1. What evidence establishes D-glucose, L-glucose or a mixture, and does the identification method discriminate those configurations? provenance
  2. Does the intended operation require a defined anomer, and what evidence establishes its presence under the actual conditions? action
Glucose amount and assay Establish how much glucose is present and what an analytical result permits an agent to conclude.

Hydration, reporting basis, assay selectivity and sample preparation can turn superficially similar glucose values into different quantities.

Quantity basis

Make glucose mass, molar amount and concentration interpretable across solids and mixtures.

Hydration-corrected quantity

Record whether a stated amount refers to the supplied material, anhydrous glucose equivalent or glucose within a mixture.

  1. Does the reported mass include hydrate water, residual moisture or other constituents, and how was the glucose contribution established? measurement
  2. Is concentration reported as molarity, mass per volume or mass fraction, and what sample and volume conditions define that value? measurement

Assay interpretation

Connect a glucose result to the method, matrix and preparation that produced it.

Selectivity and sample change

Record method selectivity, calibration, uncertainty and evidence that sample handling preserved the glucose quantity being assessed.

  1. Which glucose configurations and other substances contribute to the assay response, and were relevant matrix interferences assessed? measurement
  2. What sampling, preservation and preparation history supports treating this result as representative of the original glucose content? provenance
  3. What calibration, detection range and uncertainty support comparison with the proposed acceptance criterion? measurement
Glucose physical state Describe glucose solid forms and solution behaviour sufficiently to support preparation and handling.

Solid hydration and crystallinity affect weighing and dissolution, while dissolved glucose can change anomeric composition without ceasing to be glucose.

Solid form and water

Characterise the supplied solid and distinguish bound water from other moisture.

Solid-form evidence

Record evidence for anhydrous, hydrated, crystalline or amorphous glucose and any condition changes relevant to the next operation.

  1. What measurements or material documentation establish hydrate identity, crystallinity and water content? measurement
  2. Have storage or handling exposures changed moisture content, caking or solid form enough to affect weighing or dissolution? boundary

Dissolution and equilibration

Track whether glucose is dissolved, liable to crystallise or still changing in anomeric composition.

Solution readiness

Record solvent, temperature, concentration, residual solids and elapsed time after dissolution when these govern use or measurement.

  1. At the recorded solvent composition and temperature, what evidence establishes complete dissolution and acceptable resistance to crystallisation? measurement
  2. Could mutarotation affect the planned measurement or operation, and what equilibration evidence or timing requirement applies? action
Glucose condition and use Relate glucose composition and exposure history to a specific proposed use or transformation.

A glucose identity result does not establish freedom from degradation or contamination, nor suitability for every reaction or product context.

Chemical and microbial change

Assess changes that can consume glucose or introduce products affecting its use.

Glucose integrity

Record relevant exposure to heat, pH conditions, reactive partners and microbial activity, together with evidence of changes in glucose content or impurity profile.

  1. What temperature, pH and contact history could have promoted glucose degradation or reactions with other constituents, including amino compounds? provenance
  2. What analytical or microbiological evidence establishes whether glucose was consumed or unwanted products accumulated during storage? measurement

Operation-specific fitness

Determine whether the recorded glucose material meets the requirements of a named operation.

Qualified glucose operation

Connect identity, assay, impurity and condition evidence to requirements for preparation, reaction or use as a substrate.

  1. Which requirements for configuration, concentration, impurities and microbial condition must this glucose material meet for the named operation? boundary
  2. Do the available results support proceeding, or must the material be remeasured, conditioned or rejected against those requirements? action
  3. For an enzymatic or fermentation use, what evidence shows that the intended system accepts the recorded glucose configuration and material composition? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Kinds and varieties

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • D-glucose (dextrose)
  • L-glucose
  • α-D-glucopyranose
  • β-D-glucopyranose
  • D-glucofuranose (minor ring form)
  • open-chain (aldehydo) D-glucose
  • anhydrous crystalline dextrose
  • dextrose monohydrate
  1. Which of these kinds and varieties hold for the sense of glucose this model covers, and on what evidence? provenance

Identifiers and schemes

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • Wikidata - Q37525 - Item for glucose as a chemical substance.
  • CAS Registry Number - 50-99-7 - D-glucose (unspecified anomer/solid).
  • CAS Registry Number - 921-60-8 - L-glucose.
  • CAS Registry Number - 492-62-6 - α-D-glucose.
  • CAS Registry Number - 492-61-5 - β-D-glucose.
  • PubChem CID - 5793 - D-glucose.
  • InChIKey - WQZGKKKJIJFFOK-GASJEMHNSA-N - Standard InChIKey used for D-glucose.
  • UNII - 5SL0G7R0OK - FDA substance identifier commonly used for dextrose.
  • ChEBI - CHEBI:17234 - glucose; D-glucopyranose is CHEBI:4167.
  • EC / EINECS - 200-075-1 - EC number paired with CAS 50-99-7.
  • ATC - B05CX01 - Glucose as an irrigating solution; dietary glucose is also V06DC01.
  1. Which of these identifiers and schemes hold for the sense of glucose this model covers, and on what evidence? provenance

Standards and regulation

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • USP-NF Dextrose monograph (United States Pharmacopeial Convention) - identity, assay and impurity limits for the medicinal solid.
  • European Pharmacopoeia Glucose, anhydrous and Glucose monohydrate (EDQM) - EU pharmacopoeial grades for injections and oral use.
  • Food Chemicals Codex dextrose (USP, used as a food-grade specification).
  • ISO 15197 (ISO) - accuracy and user-performance requirements for self-testing blood-glucose systems.
  • CLSI guidance on glucose measurement in blood and plasma (Clinical and Laboratory Standards Institute).
  • ADA Standards of Care (American Diabetes Association) and WHO diabetes classification documents - diagnostic cut-points for plasma glucose.
  • Codex Alimentarius standards on sugars (FAO/WHO Codex) - food identity of glucose and glucose syrup.
  • 21 CFR food-additive/GRAS framework for dextrose and related corn sugars (U.S. FDA).
  1. Which of these standards and regulation hold for the sense of glucose this model covers, and on what evidence? provenance

Real-world use

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • Measured in venous plasma, capillary blood and interstitial fluid to diagnose and manage diabetes and acute hypo- or hyperglycaemia.
  • Given intravenously as dextrose in water (commonly 5% or 10% w/v) for fluid, caloric support and hypoglycaemia treatment.
  • Used as the oral load in a glucose tolerance test.
  • Crystalline dextrose and glucose syrups are bulk sweeteners, fermentation feedstocks and pharmaceutical diluents.
  • Carbon source in microbial fermentation, cell-culture media and industrial biotechnology.
  • Building block released from starch, glycogen and cellulose in food, fuel and fibre processing.
  1. Which of these real-world use hold for the sense of glucose this model covers, and on what evidence? provenance

Typical measurements

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • molar mass (anhydrous C6H12O6) - 180.156 - g/mol
  • specific optical rotation at mutarotational equilibrium (aqueous D-glucose) - +52.5 to +53.0 - degree (sodium D-line, water)
  • melting point (α-D-glucose) - 146 - °C
  • water solubility (25 °C) - about 900 - g/L
  • fasting venous plasma glucose (non-diabetic adult reference, ADA) - 3.9-5.6 - mmol/L
  • fasting venous plasma glucose (same interval in US customary units) - 70-100 - mg/dL
  • mass concentration of common IV dextrose (D5W) - 5 - % w/v
  • osmolarity of 5% dextrose in water - about 250-280 - mOsm/L
  1. Which of these typical measurements hold for the sense of glucose this model covers, and on what evidence? provenance

Failure modes and hazards

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • Hypoglycaemia from excess insulin, missed meals, or over-infusion of insulin relative to dextrose; seizures and death if untreated.
  • Hyperglycaemia, diabetic ketoacidosis and hyperosmolar states when insulin action is insufficient.
  • Unpreserved whole-blood samples continue glycolysis and report falsely low glucose unless fluoride or prompt separation is used.
  • Anhydrous dextrose is hygroscopic and can hydrate, changing assay and water content against a pharmacopoeial limit.
  • Maillard browning with amino compounds and caramelization on heating spoil foods, parenteral admixtures and culture media.
  • Hypertonic dextrose extravasation injures tissue; concentrated infusions can cause osmotic shifts.
  • Self-monitoring systems can mis-read when haematocrit, some sugars (e.g. maltose on older GDH-PQQ strips), or hypoxia interfere.
  • Interstitial continuous monitors lag blood glucose during rapid change, so treatment on the sensor alone can miss acute hypo- or hyperglycaemia.
  1. Which of these failure modes and hazards hold for the sense of glucose this model covers, and on what evidence? provenance

Regional variation

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • United States pharmacopoeia and hospital practice name the medicinal solid dextrose; European pharmacopoeias and most clinical language name it glucose.
  • Laboratory and meter results are reported in mg/dL in the United States and in mmol/L in most other health systems (divide mg/dL by 18).
  • Diagnostic fasting and OGTT cut-points have differed slightly among ADA, WHO and some national programmes.
  • Industrial dextrose is usually maize-derived in the US and often wheat, potato or cassava elsewhere, which changes allergen, GMO and religious-status labelling.
  • Retail 'glucose syrup' in Europe is a starch hydrolysate; in the US the nearest bulk product is often labelled corn syrup, which is not crystalline D-glucose.
  1. Which of these regional variation hold for the sense of glucose this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • fructose - Ketose rather than aldose; Seliwanoff-positive; glucose-oxidase and hexokinase/G6PD assays that are specific for glucose do not measure fructose.
  • galactose - C4-epimer of glucose; not a substrate of glucose oxidase; distinguished by galactose dehydrogenase or chromatography.
  • mannose - C2-epimer; separated from glucose by chromatography or by enzymes that are C2-specific; not the circulating plasma hexose.
  • maltose - Reducing disaccharide of two glucose units; acid or enzymatic hydrolysis yields glucose; older GDH-PQQ meters may read maltose as glucose, unlike glucose-oxidase strips.
  • sucrose - Non-reducing glucosyl-fructoside; negative Benedict/Fehling until hydrolysed; invertase or acid inversion separates it from free glucose.
  • sorbitol (D-glucitol) - Alditol with no aldehyde; non-reducing; does not mutarotate or react in glucose-oxidase assays.
  • glucose syrup / dextrin - Polydisperse starch hydrolysates, not a single C6 species; dextrose equivalent and oligosaccharide profile (HPLC) separate them from crystalline D-glucose.
  • glucose 6-phosphate - Phosphorylated intracellular metabolite; ion-exchange or specific G6PD without hexokinase distinguishes it from free glucose.
  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of glucose this model covers, and on what evidence? provenance

Sources

  1. Nomenclature of Carbohydrates (IUPAC Recommendations 1996) - Ring/open-chain forms, anomers, D/L configuration, and the specialist identity of glucose as an aldohexose.
  2. PubChem Compound Summary for CID 5793, D-Glucose - CAS, InChIKey, UNII, molar mass, and common identifiers for D-glucose.
  3. Wikidata item Q37525 (glucose) - Cross-scheme identity of the substance in an open registry.
  4. USP-NF monograph: Dextrose - Pharmacopoeial distinction of anhydrous dextrose as a defined solid, and the US name dextrose.
  5. European Pharmacopoeia monographs: Glucose, anhydrous and Glucose monohydrate - EU naming (glucose vs dextrose) and the anhydrous/monohydrate grades used in medicines and infusions.
  6. ISO 15197, In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus - How glucose is specified as a measured clinical analyte and the performance rules for meters.
  7. Standards of Care in Diabetes (Diabetes Care, American Diabetes Association, annual) - Fasting and diagnostic plasma-glucose ranges and the clinical use of the molecule as an analyte.

What the second pass must settle

  • Does registry entry vr.tr.glucose intentionally cover both D- and L-glucose, or should D-glucose be its default interpretation while preserving unresolved configuration explicitly?
  • Which existing Vercy models own solid forms, chemical mixtures and biological samples, and how should glucose occurrences link to them without duplicating ownership?
  • Which authoritative references and validated methods should establish identity, water content, assay selectivity and uncertainty for the material contexts this model will support?
  • Which condition-dependent solubility, mutarotation and degradation evidence is needed before agents can make quantitative preparation or storage decisions?
  • Which intended-use specifications should govern purity, impurity and microbiological acceptance, and which of those requirements belong in neighbouring product or process models?